Basics Amylyx Pharmaceuticals, Inc. IPO Date: January 7, 2022 Sector: Healthcare Industry: Biotech Market Cap: $492.06M Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 3.46% Avg Daily Range (30 D): $0.21 | 4.16% Avg Daily Range (90 D): $0.18 | 4.23% Institutional Daily Volume Avg Daily Volume: 1.12M Avg Daily Volume (30 D): .92M Avg Daily Volume (90 D): .78M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 100 Avg Trade Size (Sh.) (90 D): 103 Institutional Trades Total Inst.Trades: 1,278 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $.83M Avg Inst. Trade (90 D): $.95M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.28M Avg Closing Trade (30 D): $.88M Avg Closing Trade (90 D): $1.43M Avg Closing Volume: 134.34K     News Oct 18, 2024 @ 11:26 AM Why Amylyx Pharmaceuticals Stock Was So Healthy Th... Source: Eric Volkman May 10, 2024 @ 6:01 PM Breaking Down Amylyx Pharma: 9 Analysts Share Thei... Source: Benzinga Insights May 9, 2024 @ 12:15 PM Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Los... Source: Zacks Equity Research Apr 12, 2024 @ 1:22 PM The Zacks Analyst Blog Highlights Bristol Myers, M... Source: Zacks Equity Research Apr 10, 2024 @ 5:19 PM Biotech Stock Roundup: MRNA Up on Vaccine Data, BM... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.1 $-.42 $-.54 Diluted EPS $-3.1 $-.42 $-.54 Revenue $ -1.27M $ M $ -.67M Gross Profit $ $ $ -.67M Net Income / Loss $ -218.86M $ -35.91M $ -37.55M Operating Income / Loss $ -230.4M $ -37.8M $ -40.65M Cost of Revenue $ .01M $ M $ M Net Cash Flow $ -110.06M $ -17.62M $ 5.56M PE Ratio